摘要：目的 探讨托伐普坦治疗急性心肌梗死(AMI)合并心力衰竭的疗效及对患者血清hs-CRP、NT-proBNP表达的影响。方法 选取我院2016年8月～2018年9月收治的AMI合并心力衰竭患者84例，按随机数字表法分为对照组和观察组，各42例。对照组常规予以急救治疗与抗心衰药物治疗，观察组同时联合托伐普坦治疗，比较两组疗效及血清hs-CRP、NT-proBNP水平。结果 观察组总有效率为95.24%，高于对照组的78.57%(P<0.05)。治疗1周后，观察组血清hs-CRP、NT-proBNP水平均低于对照组(P<0.05)。结论 托伐普坦治疗急性心肌梗死合并心力衰竭有助于提高疗效，改善血清hs-CRP、NT-proBNP指标。

    关键词：急性心肌梗死;心力衰竭;托伐普坦;hs-CRP;NT-proBNP

    中图分类号：R541.6;R542.2 文献标识码：A DOI：10.3969/j.issn.1006-1959.2019.16.041

    文章编号：1006-1959(2019)16-0127-02

    Abstract：Objective To investigate the effect of tolvaptan on acute myocardial infarction (AMI) complicated with heart failure and its effect on serum hs-CRP and NT-proBNP expression. Methods 84 patients with AMI complicated with heart failure admitted to our hospital from August 2016 to September 2018 were enrolled. The patients were divided into the control group and the observation group according to the random number table ......